This indicates that genetic mutations affecting epigenetic modifiers (such as ASXL1 or EZH2), transcription factors (RUNX1) or TP53 fail to overcome the dependency of the MDS progenitor cells on a survival signal mediated by BCL-2. Here, EZH2 is linked to myelodysplastic syndrome.